These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 2979800
1. Multidisciplinary evaluation of rat renal cell carcinoma. Karthaus HF, Feitz WF, vd Meijden AP, Schalken JA, Beck JL, Hendriks BT, Jap PH, Vooijs GP, Debruyne FM, Ramaekers FC. In Vivo; 1987; 1(6):335-41. PubMed ID: 2979800 [Abstract] [Full Text] [Related]
2. Multiparameter analysis of four human renal cell carcinoma xenografts in nude mice. Karthaus HF, Feitz WF, Ramaekers FC, Beck JL, Hendriks BT, Schalken JA, Kurth KH, Jap PH, Debruyne FM. In Vivo; 1987; 1(6):327-34. PubMed ID: 2485135 [Abstract] [Full Text] [Related]
3. Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma. Gerharz CD, Moll R, Störkel S, Ramp U, Hildebrandt B, Molsberger G, Koldovsky P, Gabbert HE. Am J Pathol; 1995 Apr; 146(4):953-62. PubMed ID: 7717462 [Abstract] [Full Text] [Related]
4. Renal cell carcinoma in the Wistar-Lewis rat: a model for studying the mechanisms of cholesterol acquisition by a tumor in vivo. Clayman RV, Bilhartz LE, Buja LM, Spady DK, Dietschy JM. Cancer Res; 1986 Jun; 46(6):2958-63. PubMed ID: 3486039 [Abstract] [Full Text] [Related]
5. Establishment and characterization of five new human renal tumor xenografts. Beniers AJ, Peelen WP, Schaafsma HE, Beck JL, Ramaekers FC, Debruyne FM, Schalken JA. Am J Pathol; 1992 Feb; 140(2):483-95. PubMed ID: 1739137 [Abstract] [Full Text] [Related]
6. [Immunohistochemical analysis of 42 renal cell carcinomas and one oncocytoma with mono- and polyclonal antibodies against vimentin and cytokeratin]. Beham A, Ratschek M, Zatloukal K, Denk H, Lackinger E. Verh Dtsch Ges Pathol; 1989 Feb; 73():392-5. PubMed ID: 2482624 [Abstract] [Full Text] [Related]
7. Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma. Hashimura T, Tubbs RR, Connelly R, Caulfield MJ, Trindade CS, McMahon JT, Galetti TP, Edinger M, Sandberg AA, Dal Cin P. Cancer Res; 1989 Dec 15; 49(24 Pt 1):7064-71. PubMed ID: 2582448 [Abstract] [Full Text] [Related]
8. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips]. Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G. Verh Dtsch Ges Pathol; 1999 Dec 15; 83():225-32. PubMed ID: 10714215 [Abstract] [Full Text] [Related]
9. Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro. Gerharz CD, Moll R, Störkel S, Ramp U, Thoenes W, Gabbert HE. Am J Pathol; 1993 Mar 15; 142(3):851-9. PubMed ID: 7681259 [Abstract] [Full Text] [Related]
10. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat. Patel SK, Ma N, Monks TJ, Lau SS. Mol Carcinog; 2003 Nov 15; 38(3):141-54. PubMed ID: 14587099 [Abstract] [Full Text] [Related]
11. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma. Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ. Carcinogenesis; 2006 Mar 15; 27(3):499-507. PubMed ID: 16344273 [Abstract] [Full Text] [Related]
12. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis. Ljungberg B. Scand J Urol Nephrol Suppl; 1986 Mar 15; 100():1-47. PubMed ID: 3472340 [Abstract] [Full Text] [Related]
13. Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma. Schafhauser W, Liedl T, Elsässer D, Zörcher T, Schrott KM. Anticancer Res; 1999 Mar 15; 19(2C):1471-5. PubMed ID: 10365126 [Abstract] [Full Text] [Related]